Skip to content
Explicyte Oncology CRO logo
  • Discovery

    FFPE target discovery

    Custom biospecimen sourcing

    Target identification & ranking

    Target expression profiling

    Data generation

    AI-ready Spatial Biology Datasets

    Explicyte 10x Genomics certified service provider

    Across Visium, Xenium, Chromium

    Explore 10x services →

    Emerging IO Targets: pipeline overview

    Browse database →
  • Preclinical

    Functional efficacy and MoA

    Tumor killing assays

    ADCC · T-cell · Antigen-specific

    Immune function & modulation

    Activation · Migration · MLR · Macrophage Polarization · Germinal Center Reaction

    Safety

    Cytokine release

    Additional capabilities

    Patient-Derived 3D tumor models

    Immune-native organoids · Tumor fragments

    Modality-specific assays

    ADCs · Multispecifics & engagers

    Xenium for cells

  • Trials

    Biomarker analysis

    Transcriptomic biomarkers

    Spatial transcriptomics · scRNAseq

    ISO-certified pathology services

    IHC/IF assay development · Assay validation · TLS scoring

    Peripheral biomarkers

    Proteomics · Flow cytometry · scRNAseq

    Explicyte is ISO 9001 and ISO 13485 certified for biomarker and immuno-oncology services

    Certified IHC/IF biomarker services

    Clinical-grade quality management

    Our tissue biomarker services →

    Explicyte 10x Genomics certified service provider

    10x Genomics-Certified Services

    Chromium X, Visium HD, Xenium

    Explore 10x-certified services →

  • Resources

    Publications

    Case studies

    Posters & abstracts

    IO Target Database

    Events & webinars

    News & press

  • About

    Company

    Commitments

    Careers

MultiOmics
Contact us

Oncology research resources

Oncology research resources

Explicyte contributes to oncology research through peer-reviewed publications, conference posters, oral presentations, meetings, and webinars. Explore our past and upcoming collaborative work.
Meetings & webinars

Browse by

All resources Publications Posters & abstracts Case studies IO target database Company news
How immune-excluded lung tumors differ from infiltrated ones — and why it matters for immunotherapy
Publication Oct 2026

How immune-excluded lung tumors differ from infiltrated ones — and why it matters for immunotherapy

Read more
Large-scale spatial atlas of CCR8 expression across TLS maturity in solid tumors
Poster ESMO · 2026

Large-scale spatial atlas of CCR8 expression across TLS maturity in solid tumors

Read more
STAMP-Xenium: a cost-effective targeted extension of scRNA-seq
Poster Precision Medicine 2026 · 2026

STAMP-Xenium: a cost-effective targeted extension of scRNA-seq

Read more
From cell phenotype to spatial relationships: multiplex digital pathology in NSCLC
Case Study Aug 27, 2026

From cell phenotype to spatial relationships: multiplex digital pathology in NSCLC

Read more
Reserve Your Atera Slot for 2026
News Jul 15, 2026

Reserve Your Atera Slot for 2026

Read more
How tumor-derived GABA disables tumor TLSs and drives anti-PD-1 resistance in cancer
Publication Jul 2026

How tumor-derived GABA disables tumor TLSs and drives anti-PD-1 resistance in cancer

Read more
How a CD52⁺ myeloid subset drives mesenchymal breast cancer stemness through membrane-bound TGF-β1
Publication Jul 2026

How a CD52⁺ myeloid subset drives mesenchymal breast cancer stemness through membrane-bound TGF-β1

Read more
MaaT Pharma: Advancing a pipeline of novel microbiome therapies across oncology
Sponsor Story Jun 10, 2026

MaaT Pharma: Advancing a pipeline of novel microbiome therapies across oncology

Read more
Cure51 – A unique Xenium dataset of cancer outliers
Sponsor Story Jun 8, 2026

Cure51 – A unique Xenium dataset of cancer outliers

Read more

Explicyte Oncology CRO logo

The precision oncology CRO

229 cours de l’Argonne
33000 Bordeaux, France

Subscribe to our newsletter

By subscribing, you agree to receive Explicyte’s email updates, tailored to your interests based on the emails you open and the links you click. You can unsubscribe at any time. Privacy policy

Explicyte

  • About us
  • Commitments
  • News & Press
  • Careers
  • Contact

Discovery

  • FFPE tissues
  • Target identification
  • Target expression
  • Spatial biology for AI
  • 10x CSP services

Preclinical

  • Tumor killing
  • Immuno-modulation
  • Cytokine release
  • Patient-derived 3D models
  • ADC, Multispecifics

Trials

  • Transcriptomics
  • Peripheral markers
  • ISO-certified pathology
  • TLS detection

Multiomics

  • Atera
  • Xenium
  • Visium HD
  • scRNAseq
  • Digital pathology
  • Bioinformatics

Resources

  • Publications
  • Posters
  • Events & webinars
  • Case studies
  • IO targets database

© 2026 Explicyte. All rights reserved.

© 2026 Explicyte. All rights reserved.

    • Privacy policy
    • Terms of Use
    • Terms of service

 

Linkedin Youtube
Explicyte

Oncology CRO

Also at Explicyte Multi-Omics services Spatial Biology, scRNA-seq, Proteomics, Flow Cytometry, Bioinformatics 10x Genomics Certified Service Provider

Discovery

Overview
  • Custom biospecimen sourcing
  • Target identification & ranking
  • Target expression profiling
  • AI-Ready spatial biology datasets
10x Genomics Certified Service Provider

Preclinical

Overview
  • Patient-derived 3D tumor models
  • Xenium STAMP single-cell profiling

Tumor killing assays

Overview
  • ADCC
  • T-cell killing
  • Antigen-specific killing

Immune modulation assays

Overview
  • Immune cell activation
  • Cell Migration
  • Mixed lymphocyte reaction
  • Macrophage polarization
  • Germinal center reaction
  • Cytokine release

Modality-specific assays

Overview
  • Multispecifics & engagers
  • Antibody-drug conjugates (ADC)

Trials

Overview
  • Peripheral biomarker analysis
  • Transcriptomic biomarkers
  • ISO-certified pathology services
  • Multiplex IF panel for TLS scoring
10x Genomics Certified Service Provider
Certified IHC/IF tissue biomarker services ISO 9001 and ISO 13485 certified

Resources

Overview
  • Publications
  • Case studies
  • Posters & scientific abstracts
  • IO targets database
  • Events & webinars
  • News & press

About

Overview
  • Company
  • Commitments
  • Careers
Contact us